20th Oct 2008 - (NASDAQ: TEVA) announced today that the US Food and Drug Administration (FDA) has granted approval for the company's abbreviated new drug application (ANDA) for Fentanyl Transdermal System, 25 meg/hour, 50 meg/hour, 75 meg/hour and 100 meg/hour, the AB-rated generic equivalent of
FDA approves opioid pain reliever with required risk reduction plan.
Par to begin shipping clonidine TDS in the near future.
Plast-Ex and PACKEX Toronto will co-locate in 2011 as the core of Canada's first advanced technology manufacturing event; increases show total to 62 in eight countries.
OrthoTec conferences and exhibitions will debut in Warsaw, Indiana, and Zurich, Switzerland.
Performance seen as evidence of business vitality amidst economic downturn.
Companies partner to reduce risk and time in design and execution of adaptive clinical trials for bio-tech and pharmaceutical companies
GVK Biosciences (GVK BIO), Asia’s leading integrated research services provider and Quantitative Solutions (QS), a modelling and simulation (M&S) consultancy to the pharmaceutical and biotech industry, announced a strategic partnership to develop and market clinical trial outcome databases. The databases capture summary level data for the clinical safety and efficacy outcomes from publicly available data sources.
HollisterStier expands electronic regulatory submission capabilities with Datafarm's S-Cubed eCTD.
Datafarm accommodates a surge in growth by moving its EU headquarters to a larger, more central location.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.